These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30631973)

  • 1. Pediatric Formulations: Knowledge Gaps Limiting the Expedited Preclinical to Clinical Translation in Children.
    Lavan M; Byrn SR; Knipp G
    AAPS PharmSciTech; 2019 Jan; 20(2):73. PubMed ID: 30631973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatrics Formulation Initiative: proceedings from the Second Workshop on Pediatric Formulations.
    Giacoia GP; Taylor-Zapata P; Zajicek A
    Clin Ther; 2012 Nov; 34(11):S1-10. PubMed ID: 23149008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric Off-Label and Unlicensed Drug Use and Its Implications.
    Gore R; Chugh PK; Tripathi CD; Lhamo Y; Gautam S
    Curr Clin Pharmacol; 2017; 12(1):18-25. PubMed ID: 28322168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatric Formulation Initiative: selected reports from working groups.
    Giacoia GP; Taylor-Zapata P; Mattison D
    Clin Ther; 2008 Nov; 30(11):2097-101. PubMed ID: 19108797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal and pediatric oral drug delivery: Hopes and hurdles.
    Mfoafo KA; Omidian M; Bertol CD; Omidi Y; Omidian H
    Int J Pharm; 2021 Mar; 597():120296. PubMed ID: 33524524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The economics of pediatric formulation development for off-patent drugs.
    Milne CP; Bruss JB
    Clin Ther; 2008 Nov; 30(11):2133-45. PubMed ID: 19108801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric drug formulations: a review of challenges and progress.
    Ivanovska V; Rademaker CM; van Dijk L; Mantel-Teeuwisse AK
    Pediatrics; 2014 Aug; 134(2):361-72. PubMed ID: 25022739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary packaging considerations in developing medicines for children: oral liquid and powder for constitution.
    Campbell GA; Vallejo E
    J Pharm Sci; 2015 Jan; 104(1):52-62. PubMed ID: 25393927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pediatric studies initiative: after 15 years have we reached the limits of the law?
    Milne CP; Davis J
    Clin Ther; 2014 Feb; 36(2):156-62. PubMed ID: 24529287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applying "children defined daily dose" to assess appropriate dose in pediatrics.
    Zhang L; Li Y; Zeng L; Wang Z
    J Evid Based Med; 2012 Feb; 5(1):2-5. PubMed ID: 23528114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric drug formulations: challenges and potential solutions.
    Nahata MC
    Ann Pharmacother; 1999 Feb; 33(2):247-9. PubMed ID: 10084423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the pharmaceutical technologic aspects of oral pediatric drugs on patient-related outcomes: a systematic literature review.
    van Riet-Nales DA; Schobben AF; Egberts TC; Rademaker CM
    Clin Ther; 2010 May; 32(5):924-38. PubMed ID: 20685501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telemedicine for the Medicare population: pediatric, obstetric, and clinician-indirect home interventions.
    Hersh WR; Wallace JA; Patterson PK; Shapiro SE; Kraemer DF; Eilers GM; Chan BK; Greenlick MR; Helfand M
    Evid Rep Technol Assess (Summ); 2001 Aug; (24 Suppl):1-32. PubMed ID: 11569328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use and reimbursement of off-label drugs in pediatric anesthesia: the Italian experience.
    Salvo I; Landoni G; Mucchetti M; Cabrini L; Pani L
    Paediatr Anaesth; 2014 Jun; 24(6):625-31. PubMed ID: 24796404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric off-label drug use in China: risk factors and management strategies.
    Zhang L; Li Y; Liu Y; Zeng L; Hu D; Huang L; Chen M; Lv J; Yang C
    J Evid Based Med; 2013 Feb; 6(1):4-18. PubMed ID: 23557523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extemporaneous drug formulations.
    Nahata MC; Allen LV
    Clin Ther; 2008 Nov; 30(11):2112-9. PubMed ID: 19108799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products.
    Ceci A; Felisi M; Catapano M; Baiardi P; Cipollina L; Ravera S; Bagnulo S; Reggio S; Rondini G
    Eur J Clin Pharmacol; 2002 Nov; 58(8):495-500. PubMed ID: 12451425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failed Pediatric Drug Development Trials.
    Momper JD; Mulugeta Y; Burckart GJ
    Clin Pharmacol Ther; 2015 Sep; 98(3):245-51. PubMed ID: 25963725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical safety evaluations supporting pediatric drug development with biopharmaceuticals: strategy, challenges, current practices.
    Morford LL; Bowman CJ; Blanset DL; Bøgh IB; Chellman GJ; Halpern WG; Weinbauer GF; Coogan TP
    Birth Defects Res B Dev Reprod Toxicol; 2011 Aug; 92(4):359-80. PubMed ID: 21770023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological research in pediatrics: From neonates to adolescents.
    Rakhmanina NY; van den Anker JN
    Adv Drug Deliv Rev; 2006 Apr; 58(1):4-14. PubMed ID: 16533543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.